# Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

> **NCT02415257** · PHASE4 · WITHDRAWN · sponsor: **Lund University**

## Conditions studied

- Vestibular Schwannoma

## Interventions

- **DRUG:** Gentamicin

## Key facts

- **NCT ID:** NCT02415257
- **Lead sponsor:** Lund University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-04
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415257, "Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02415257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*